Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 8,119 filings
Top spenders & firms Spend by issue Political contributions Revolving door
Q2
COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE for COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE
2A
NASSAU SUFFOLK HOSPITAL COUNCIL for NASSAU SUFFOLK HOSPITAL COUNCIL
Q2
AMERICAN SUGARBEET GROWERS ASSOCIATION for AMERICAN SUGARBEET GROWERS ASSOCIATION
Q2
HOLLAND & KNIGHT LLP for WASHINGTON AND LEE UNIVERSITY
Q2
CENTER FOR INDIVIDUAL FREEDOM for CENTER FOR INDIVIDUAL FREEDOM
Q2
MARCUS G. FAUST, PC for NV ENERGY
2A
UNIVERSITY HEALTH SYSTEMS OF EASTERN CAROLINA, INC. D/B/A ECU HEALTH for UNIVERSITY HEALTH SYSTEMS OF EASTERN CAROLINA, INC. D/B/A ECU HEALTH
Q2
HOLLAND & KNIGHT LLP for LANTERIS SPACE SYTEMS F/K/A MAXAR SPACE LLC
Q2
HOLLAND & KNIGHT LLP for INDUSTRIAL TECHNOLOGY INSTITUTE D/B/A MICHIGAN MANUFACTURING TECHNOLOGY CENTER
Q2
HOLLAND & KNIGHT LLP for COMMERCIAL SPACE FEDERATION FKA COMMERCIAL SPACEFLIGHT FEDERATION
Q2
HOLLAND & KNIGHT LLP for BLUE ORIGIN LLC
Q2
VANNEVAR LABS for VANNEVAR LABS
Q2
HOLLAND & KNIGHT LLP for ASTRANIS SPACE TECHNOLOGIES CORP.
Q2
HOLLAND & KNIGHT LLP for AMERICAN SMALL MANUFACTURERS COALITION
Q2
NASSAU SUFFOLK HOSPITAL COUNCIL for NASSAU SUFFOLK HOSPITAL COUNCIL
2A
ADVANCED POLICY CONSULTING, LLC for AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION)
2A
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Q2
EQUIPMENT LEASING AND FINANCE ASSOCIATION for EQUIPMENT LEASING AND FINANCE ASSOCIATION
Q2
AMERICAN AMBULANCE ASSOCIATION for AMERICAN AMBULANCE ASSOCIATION
Q2
ADVANCED POLICY CONSULTING, LLC for AMERICAN CEMENT ASSOCIATION (FORMERLY KNOWN AS PORTLAND CEMENT ASSOCIATION)
Q2
OHIO FARM BUREAU FEDERATION for OHIO FARM BUREAU FEDERATION
Q2
ADVANCED POLICY CONSULTING, LLC for OMAHA PUBLIC POWER DISTRICT (OPPD)
Q2
VENABLE LLP for FCA US LLC
Q2
ADVANCED POLICY CONSULTING, LLC for POLARIS INDUSTRIES, INC.
Q2
THE WASHINGTON TAX & PUBLIC POLICY GROUP for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION